KRISTEN THAMES: Open Payments
NPI 1407493596 · COLLINSVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 12 payments from 7 companies in 2025. Trend: 2023 $366 · 2024 $1,169 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $227 |
| Novo Nordisk Inc | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $96 |
| ABBVIE INC. | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: BREZTRI, Ozempic, AIRSUPRA, Kerendia, JARDIANCE, VRAYLAR, FANAPT, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
